The complement system plays a central role in our innate immunity to fight pathogenic
microorganisms, foreign and altered cells, or any modified molecule. Consequences of …

The delivery of HIV-1 envelope (Env) trimer-based immunogens on the surface of
nanoparticles holds promise to promote immunogenicity with the aim of inducing a potent …

The SARS‐CoV‐2 virus outbreak revealed that these nano‐pathogens have the ability to
rapidly change lives. Undoubtedly, SARS‐CoV‐2 as well as other viruses can cause …

Immunization is a straightforward concept but remains for some pathogens like HIV-1 a
challenge. Thus, new approaches towards increasing the efficacy of vaccines are required …

The envelope glycoprotein (Env) of retroviruses, such as the Feline leukemia virus (FeLV), is
the main target of neutralizing humoral response, and therefore, a promising vaccine …

The development of HIV prophylactic vaccines is facing an impasse, since all phase IIb/III
clinical trials were halted in 2023 without demonstrating efficacy. Thus, the field is in need of …

Broadly neutralizing antibodies (bNAbs) possess favorable safety, and passive
immunization using these can prevent or control human immunodeficiency virus type 1 (HIV …

Micelles from amphiphilic polylactide-block-poly (N-acryloxysuccinimide-co-N-
vinylpyrrolidone)(PLA-bP (NAS-co-NVP)) block copolymers of 105 nm in size were …

Vaccination has been extremely effective in treating infectious illnesses for almost 200
years. Understanding immunology and advances in molecular biology have enabled the …

Viruses can be considered as one of the most common causes of human disease. The
human immunodeficiency virus (HIV) causing acquired immunodeficiency syndrome (AIDS) …